Harnessing Interactive Technologies to Improve Health Outcomes in Juvenile Idiopathic Arthritis

Simple item page
aut.relation.journalPediatric Rheumatologyen_NZ
aut.researcherRome, Keith
dc.contributor.authorCoda, Aen_NZ
dc.contributor.authorSculley, Den_NZ
dc.contributor.authorSantos, Den_NZ
dc.contributor.authorGirones, Xen_NZ
dc.contributor.authorBrosseau, Len_NZ
dc.contributor.authorSmith, DRen_NZ
dc.contributor.authorBurns, Jen_NZ
dc.contributor.authorRome, Ken_NZ
dc.contributor.authorMunro, Jen_NZ
dc.contributor.authorSingh-Grewal, Den_NZ
dc.date.accessioned2017-05-22T02:51:22Z
dc.date.available2017-05-22T02:51:22Z
dc.date.copyright2017-05-19en_NZ
dc.date.issued2017-05-19en_NZ
dc.description.abstractBackground: Children and adolescents with Juvenile Idiopathic Arthritis (JIA) typically have reduced physical activity level and impaired aerobic and anaerobic exercise capacity when compared to their non-JIA counterparts. Low intensity exercise regimens appear to be safe in children with JIA and may results in improvements in overall physical function. Poor adherence to paediatric rheumatology treatment may lead to negative clinical outcomes and possibly increased disease activity. This includes symptoms such as pain, fatigue, quality of life, longer term outcomes including joint damage, as well as increase of healthcare associated costs. Low adherence to medications such as methotrexate and biological-drugs remains a significant issue for paediatric rheumatologists, with alarming reports that less than half of the children with JIA are compliant to drug-therapy. Main body: The recent advances in interactive technology resulting in a variety of wearable user-friendly smart devices may become a key solution to address important questions in JIA clinical management. Fully understanding the impact that arthritis and treatment complications have upon individual children and their families has long been a challenge for clinicians. Modern interactive technologies can be customised and accessed directly in the hands or wrists of children with JIA. These secured networks could be accessible ‘live’ at anytime and anywhere by the child, parents and clinicians. Multidisciplinary teams in paediatric rheumatology may benefit from adopting these technologies to better understand domains such as patient biological parameters, symptoms progression, adherence to drug-therapy, quality of life, and participation in physical activities. Most importantly the use of smart devices technologies may also facilitate more timely clinical decisions, improve self-management and parents awareness in the progression of their child’s disease. Paediatric rheumatology research could also benefit from the use of these smart devices, as they would allow real-time access to meaningful data to thoroughly understand the disease-patterns of JIA, such as pain and physical activity outcomes. Data collection that typically occurs once every 1 or 3 months in the clinical setting could instead be gathered every week, day, minute or virtually live online. Arguably, few limitations in wearing such interactive technologies still exist and require further developments. Conclusion: Finally, by embracing and adapting these new and now highly accessible interactive technologies, clinical management and research in paediatric rheumatology may be greatly advanced.
dc.identifier.citationPediatric Rheumatology, 15(1), 40.
dc.identifier.doi10.1186/s12969-017-0168-y
dc.identifier.urihttps://hdl.handle.net/10292/10484
dc.publisherBioMed Central
dc.relation.urihttps://ped-rheum.biomedcentral.com/articles/10.1186/s12969-017-0168-y
dc.rights© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
dc.rights.accessrightsOpenAccessen_NZ
dc.titleHarnessing Interactive Technologies to Improve Health Outcomes in Juvenile Idiopathic Arthritisen_NZ
dc.typeJournal Article
pubs.elements-id280622
pubs.organisational-data/AUT
pubs.organisational-data/AUT/Health & Environmental Science
pubs.organisational-data/AUT/Health & Environmental Science/Clinical Sciences
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Coda Pediatr Rheumatol 2017.pdf
Size:
417.98 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
AUT Grant of Licence for Scholarly Commons Feb2017.pdf
Size:
239.25 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
School of Clinical Sciences